Centre veterinarians, as regards donor animals of semen, or team veterinarians, as regards donor animals of oocytes and embryos, shall ensure that the donor bovine, porcine, ovine, caprine and equine animals comply with the following requirements:
they were born and have remained since birth in the Union, or have entered the Union in accordance with the requirements for entry into the Union;
they come from establishments in a Member State or zone thereof, or from establishments under official control by the competent authority in a third country or territory, or a zone thereof, each of which fulfils the animal health requirements laid down in Delegated Regulation (EU) 2020/688:
for bovine animals in Article 10(1), Article 11(1), (2) and (3) and Article 12(1), (2) and (3);
for porcine animals in Article 19(1) and Article 20(1) and (2);
for ovine and caprine animals in Article 15(1), (2), (3) and (4);
for equine animals in Article 22(1) and (2);
they have been identified in accordance with requirements laid down in Regulation (EU) 2019/2035:
for bovine animals in Article 38;
for porcine animals in Article 52(1) or 54(2);
for ovine and caprine animals in Article 45(2) or (4), or Article 46(1), (2) or (3);
for equine animals in Article 58(1) or 59(1) or 62(1);
for a period of at least 30 days prior to the date of the first collection of the germinal products and during the collection period:
they have been kept in establishments which are not situated in a restricted zone established due to the occurrence in bovine, porcine, ovine, caprine or equine animals of a category A disease or of an emerging disease relevant for those animals;
they have been kept in establishments where no category D diseases relevant for those animals, except infection with bluetongue virus (serotypes 1-24) and infection with epizootic haemorrhagic disease virus, have been reported;
they have not been in contact with animals from establishments situated in a restricted zone referred to in point (i) or from establishments which do not meet the conditions referred to in point (ii);
they have not been used for natural breeding;
on the day of collection of the semen, oocytes or embryos, they have not shown any symptoms or clinical signs of any of the following:
the category D diseases referred to in point (d)(ii);
infection with bluetongue virus (serotypes 1-24);
infection with epizootic haemorrhagic disease virus;
the emerging diseases referred to in Article 6 of Regulation (EU) 2016/429;
they comply with the additional animal health requirements set out:
for bovine animals in Article 20, and in Part 1 and Chapters I, II and III of Part 5 of Annex II;
for porcine animals in Article 21, and in Part 2 and Chapters I and IV of Part 5 of Annex II;
for ovine and caprine animals in Article 22, and in Part 3 and Chapters I, II and III of Part 5 of Annex II;
for equine animals in Article 23, and in Part 4 of Annex II.